Trial Details

COMPLETED
Basic Information
Clinical ID c1325
Identifier NCT00572585
Trial Title Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: AEB071|DRUG: Placebo
Participant Information
Sponsor Novartis Pharmaceuticals
City Mobile
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-04-10
Primary Completion Date 2025-04-12
Completion Date 2025-04-12